Institute for Health Data Science, Lanzhou University | China
Accelerating the translation of evidence to practice in China.
Learn more about about the Institute for Health Data Science team and how PEERSS supports their work.
Partner team overview
Under the PEERSS partnership, the Institute of Health Data Science has worked to make evidence more accessible and decisions more collaborative in China.
With PEERSS funding and support, the Institute has worked to:
Disseminate social and health-related Chinese COVID-19 literature and share the Chinese experience with other countries and organizations.
Establish a COVID-19 Chinese evidence sharing platform which is accessible to researchers and decision-makers around the world.
Provide Chinese evidence and relevant policies to support other PEERSS partner teams.
Gain the trust of key decision-makers and stakeholders in the evidence-informed policymaking space.
Moving forward, partners from China will continue to promote evidence-informed policymaking by:
Conducting methodological research on the evidence-based social science ecosystem.
Holding stakeholder dialogues and workshops with key actors to promote international collaboration.
Conducting a rapid synthesis and developing a policy brief that is informed by that synthesis.
Meet the experts from China.
Publications, policy briefs and other resources from the Institute for Health Data Science
» Clinical Practice Guidelines Registry: Toward Reducing Duplication, Improving Collaboration, and Increasing Transparency
Chen Y, Guyatt GH, Munn Z, Florez ID, Marušić A, Norris SL, Kredo T, Qaseem A.
» The reporting checklist for public versions of guidelines: RIGHT-PVG
Wang X, Chen Y, Akl EA, Tokalić R, Marušić A, Qaseem A, Falck-Ytter Y, Lee MS, Siedler M, Barber SL, Zhang M. Implementation Science. 2021 Dec;16(1):1-0.
» Coronavirus disease (COVID-19): a scoping review
Lv M, Luo X, Estill J, Liu Y, Ren M, Wang J, Wang Q, Zhao S, Wang X, Yang S, Feng X. Eurosurveillance. 2020 Apr 16;25(15):2000125.
» Rapid advice guidelines for management of children with COVID-19
Liu E, Smyth RL, Luo Z, Qaseem A, Mathew JL, Lu Q, Fu Z, Zhao X, Zhao S, Estill J, Chan ES. Annals of translational medicine. 2020 May;8(10).
» Avoidable waste in the production and reporting of evidence
Chen YL, Yang KH. The Lancet. 2009 Sep 5;374(9692):786
» CONSORT 2010
Chen YL, Yang KH. CONSORT 2010. The Lancet. 2010 Jul 24;376(9737):230.
» Managing conflicts of interest in practice guidelines panels
Chen Y, Yang K, Norris SL. Jama. 2017 Sep 5;318(9):866-7.
» Clinical practice guidelines in China
Chen Y, Wang C, Shang H, Yang K, Norris SL. Bmj. 2018 Feb 5;360.
» Clinical practice guidelines for COVID-19
Chen Y, Yu X. Integrative Medicine Research. 2020 Sep 1
» Issue brief on Treatment for COVID-19 Pandemic
» Issue brief on pathophysiology and clinical manifestation for COVID-19 Pandemic
Have a question about the research from China?
Use the contact form below to submit a message to the PEERSS team or reach out via email.
Explore the World of Evidence
Trinidad and Tobago